Commentary

Med checks: 15 minutes can make a difference


 

References

“How to avoid burning out and keep your spark” by Drs. Phil Bohnert and Anne O’Connell (Current Psychiatry, January 2006) offers welcome insights in this time of high stress for clinical psychiatrists. The authors’ analysis and suggestions seem worthwhile.

When discussing “External causes for burnout,” however, the authors took a cheap, unnecessarily harsh shot at the “15-minute” medication check as “probably the most demoralizing hazard.” That would only be true if the psychiatrist does not see the value of such brief interactions or cannot do them properly.

We can indeed help patients within 15 minutes and make empathetic connections by asking about their lives and what they value. Ignoring this skill slights the many psychiatrists who—because they want to serve the underserved but lack adequate funding—do quite well within that time frame.

Further, some patients, depending on their pathology and personality, prefer shorter visits. A truncated visit may help these patients stay in treatment.

Finally, the 15-minute visit is not all managed care’s doing: Brief med checks were common in community psychiatry long before the ascendance of managed care.

As the old saying goes for child rearing, it’s not (only) the quantity of time, it’s the quality of time together.

H. Steven Moffic, MD
Milwaukee, WI

The authors respond

We thank Dr. Moffic for his thoughtful comments. We do not wish to negate the value of the 15-minute medication check or its utility in increasing public access to psychiatric care.

It must be noted that psychiatrists have reported anecdotally and in the literature1,2 that such a brief visit can frustrate the desire to handle both medications and psychotherapy. For those who envisioned a psychotherapy-based practice, it may well remain a burnout hazard.

We welcome further discussion of the pros and cons of the 15-minute med check.

Phil Bohnert, MD
Anne O’Connell, MD, PhD
University of Hawaii, Honolulu

Recommended Reading

ADHD: Switching to Atomoxetine Can Help
MDedge Psychiatry
Conditioned Placebo Dose Reduction Tested for ADHD
MDedge Psychiatry
Some Patients Respond Well to Reduced Doses of Atomoxetine
MDedge Psychiatry
Narcolepsy Drug Is Safe, Effective for ADHD
MDedge Psychiatry
Compliance Puts New Spin on Psychosis Treatment : Adolescents with prodromal psychosis had better outcomes with antidepressants than antipsychotics.
MDedge Psychiatry
Symptoms of Pediatric Delirium Often Overlooked, Mistreated
MDedge Psychiatry
Some Symptoms of PDD Respond to Medications : Pharmacotherapy has shown some promise for reducing aggression, inattention, and hyperactivity.
MDedge Psychiatry
Puberty and Body Dissatisfaction in Girls
MDedge Psychiatry
Clinical Capsules
MDedge Psychiatry
Dysthymia in Older Adults Needs Further Study
MDedge Psychiatry